ReShape Lifesciences (RSLS) Competitors $3.16 -0.05 (-1.41%) Closing price 08/14/2025Extended Trading$3.16 0.00 (0.00%) As of 08/14/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock RSLS vs. BIAF, ABT, ISRG, BSX, SYK, MDT, BDX, IDXX, EW, and RMDShould you be buying ReShape Lifesciences stock or one of its competitors? The main competitors of ReShape Lifesciences include bioAffinity Technologies (BIAF), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), IDEXX Laboratories (IDXX), Edwards Lifesciences (EW), and ResMed (RMD). These companies are all part of the "medical" sector. ReShape Lifesciences vs. Its Competitors bioAffinity Technologies Abbott Laboratories Intuitive Surgical Boston Scientific Stryker Medtronic Becton, Dickinson and Company IDEXX Laboratories Edwards Lifesciences ResMed bioAffinity Technologies (NASDAQ:BIAF) and ReShape Lifesciences (NASDAQ:RSLS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations and institutional ownership. Is BIAF or RSLS more profitable? ReShape Lifesciences has a net margin of -69.71% compared to bioAffinity Technologies' net margin of -152.16%. ReShape Lifesciences' return on equity of -547.65% beat bioAffinity Technologies' return on equity.Company Net Margins Return on Equity Return on Assets bioAffinity Technologies-152.16% -845.68% -181.92% ReShape Lifesciences -69.71%-547.65%-79.89% Do institutionals and insiders have more ownership in BIAF or RSLS? 1.6% of bioAffinity Technologies shares are owned by institutional investors. Comparatively, 22.1% of ReShape Lifesciences shares are owned by institutional investors. 16.9% of bioAffinity Technologies shares are owned by insiders. Comparatively, 0.0% of ReShape Lifesciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has higher valuation & earnings, BIAF or RSLS? ReShape Lifesciences has lower revenue, but higher earnings than bioAffinity Technologies. bioAffinity Technologies is trading at a lower price-to-earnings ratio than ReShape Lifesciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiobioAffinity Technologies$9.36M0.74-$9.04M-$0.70-0.35ReShape Lifesciences$8.01M1.06-$7.13M-$108.27-0.03 Does the media prefer BIAF or RSLS? In the previous week, bioAffinity Technologies and bioAffinity Technologies both had 1 articles in the media. ReShape Lifesciences' average media sentiment score of 1.88 beat bioAffinity Technologies' score of 0.94 indicating that ReShape Lifesciences is being referred to more favorably in the news media. Company Overall Sentiment bioAffinity Technologies Positive ReShape Lifesciences Very Positive Do analysts prefer BIAF or RSLS? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score bioAffinity Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00ReShape Lifesciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk and volatility, BIAF or RSLS? bioAffinity Technologies has a beta of 2.53, indicating that its stock price is 153% more volatile than the S&P 500. Comparatively, ReShape Lifesciences has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500. SummaryReShape Lifesciences beats bioAffinity Technologies on 8 of the 13 factors compared between the two stocks. Get ReShape Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RSLS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RSLS vs. The Competition Export to ExcelMetricReShape LifesciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.49M$7.16B$5.75B$9.76BDividend YieldN/A1.19%4.10%4.04%P/E Ratio-0.0326.1883.2726.59Price / Sales1.0655.36535.03111.31Price / CashN/A21.7237.4459.26Price / Book-0.367.0910.556.58Net Income-$7.13M$176.42M$3.27B$265.95M7 Day PerformanceN/A0.83%0.40%0.17%1 Month Performance-67.67%3.53%7.31%3.90%1 Year Performance-99.66%7.54%46.58%19.67% ReShape Lifesciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RSLSReShape Lifesciences0.1288 of 5 stars$3.16-1.4%N/A-99.7%$8.49M$8.01M-0.0350Gap DownHigh Trading VolumeBIAFbioAffinity Technologies0.3846 of 5 stars$0.25-1.7%N/A-83.9%$7.22M$9.36M-0.3610ABTAbbott Laboratories4.8855 of 5 stars$132.02-0.4%$144.47+9.4%+17.1%$230.77B$41.95B16.54114,000Positive NewsISRGIntuitive Surgical4.9616 of 5 stars$468.44-1.6%$595.95+27.2%-3.9%$170.69B$9.15B65.3315,638Positive NewsBSXBoston Scientific4.8682 of 5 stars$105.18-0.9%$117.50+11.7%+29.1%$157.32B$16.75B62.6153,000Positive NewsSYKStryker4.6165 of 5 stars$390.69-0.9%$430.10+10.1%+8.6%$150.71B$22.60B51.7553,000Positive NewsInsider TradeMDTMedtronic4.9691 of 5 stars$92.02-0.7%$101.15+9.9%+4.7%$118.84B$33.54B25.3595,000Positive NewsAnalyst ForecastBDXBecton, Dickinson and Company4.4305 of 5 stars$194.70-2.5%$211.44+8.6%-20.4%$57.23B$20.18B35.0274,000Positive NewsIDXXIDEXX Laboratories4.5209 of 5 stars$641.35-0.7%$649.44+1.3%+34.4%$51.65B$3.90B53.4011,000Positive NewsInsider TradeEWEdwards Lifesciences4.3386 of 5 stars$80.92-1.1%$85.90+6.2%+16.5%$48.04B$5.44B11.6415,800News CoveragePositive NewsAnalyst UpgradeRMDResMed4.6332 of 5 stars$285.76-2.7%$274.83-3.8%+12.1%$43.01B$5.15B30.0510,600Positive News Related Companies and Tools Related Companies BIAF Alternatives ABT Alternatives ISRG Alternatives BSX Alternatives SYK Alternatives MDT Alternatives BDX Alternatives IDXX Alternatives EW Alternatives RMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RSLS) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReShape Lifesciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ReShape Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RSLS Stock Alerts